Last reviewed · How we verify
Free Choice
At a glance
| Generic name | Free Choice |
|---|---|
| Sponsor | HIV Prevention Trials Network |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer (PHASE3)
- Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases (PHASE2, PHASE3)
- Plantar Pressure and Acceptance of the LEEF-shoe in Individuals With Diabetes-related Neuropathy (NA)
- PREVENT Pilot HPV - Related Cancers Trial (NA)
- Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics (NA)
- Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment
- Mulligan and Proprioceptive Neuromuscular Facilitation Techniques in Individuals With Rotator Cuff Lesions (NA)
- Physical Exercise and Biomolecular Analysis to Reduce Uremic Toxins in Chronic Kidney Disease: An Exploratory Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Free Choice CI brief — competitive landscape report
- Free Choice updates RSS · CI watch RSS
- HIV Prevention Trials Network portfolio CI